Back to Type 2 Diabetes
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01007266

NCT01007266
Completed Phase 2

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with type 2 diabetes by your doctor.
  • You are between 12 and 20 years old when you join the trial.
  • Your most recent HbA1c blood sugar level result was 7% or higher (this is a test that shows your average blood sugar over the past few months).

Who may not be able to join:

  • You have another serious health condition that the trial doctors feel might make it hard for you to fully take part in the study (confirm with trial site).
  • You have a significant mental health condition, a cognitive (thinking or learning) difficulty, or communication challenges that the trial doctors feel would make it hard for you to interact with the study team, or that could put the study team at risk; this also includes anyone who currently has thoughts of harming themselves or others, or has a history of being arrested for violent behavior, or has been suspended or expelled from school for violent behavior.
  • You are currently pregnant or planning to become pregnant within the next 6 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 2
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Registry
clinicaltrials_gov
Start date
9 October 2009

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

To evaluate the effect of a minimally invasive intervention (the buddy system) on hemoglobin A1c levels in adolescents with T2DM.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov